4G3-25305-82393
3 vaccinations
12 coded responses
42 check-ins
11 free-text entries
1 call case
- Sex
- —
- Age at first dose
- 66+
- ZIP prefix
- 015 / MA
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-03-08
Registered in v-safe
-
2021-03-08
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-08
-
2021-03-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-10
-
2021-03-11
Survey response — days 1–6 daily, dose 1MedDRA: Insomnia — Feeling: Good · Fatigue or tirednessFree text: Difficulty sleepingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Survey response — days 1–6 daily, dose 1MedDRA: Night sweats — Feeling: Good · Fatigue or tirednessFree text: Night sweats 3 nights may be related to other conditionsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-06-07
- 2021-09-08
-
2021-12-24
Dose 2 — Moderna
-
2021-12-25
Survey response — days 1–6 daily, dose 2MedDRA: Paraesthesia, Pruritus — Feeling: Fair · Site: Pain, Redness, SwellingFree text: Slight itchy or prickly skin. May be due to cancer treatmentMedDRA releases: 2024-11 · check-in free text available
-
2021-12-26
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease — Feeling: Good · Site: Pain, Redness, SwellingFree text: Cancer symptoms and cancer drugs overlap some of above none newMedDRA releases: 2024-11 · check-in free text available
-
2021-12-27
Survey response — days 1–6 daily, dose 2MedDRA: Neoplasm malignant, Night sweats — Feeling: Good · Site: Pain, Redness, Swelling, ItchingFree text: Night sweats most likely from cancerMedDRA releases: 2024-11 · check-in free text available
-
2021-12-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-12-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-12-31
-
2022-01-07
Survey response — day 14, dose 2MedDRA: Office visit, Rash — Feeling: GoodFree text: I had a rash on upper thigh. My oncologist said unlikely from my treatment. Treated with Allegra (2) until gone 3 days and still on 1 last day.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-14
- 2022-01-21
- 2022-01-28
- 2022-02-04
- 2022-03-27
- 2022-06-25
-
2022-07-19
Dose 3 — Pfizer-BioNTech
- 2022-07-19
-
2022-07-21
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2022-07-22
Survey response — days 1–6 daily, dose 3MedDRA: Injection site pain, Pre-existing disease — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, DiarrheaFree text: I am on chemo so only my sore arm at shot site is related. Possibly mild fatigue.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-23
Survey response — days 1–6 daily, dose 3MedDRA: Unevaluable event — Feeling: Good · Fatigue or tiredness, NauseaFree text: Probably chemo relatedMedDRA releases: 2024-11 · check-in free text available
-
2022-07-24
Survey response — days 1–6 daily, dose 3MedDRA: Chemotherapy, Neoplasm malignant — Feeling: Good · DiarrheaFree text: Cancer or chemoMedDRA releases: 2024-11 · check-in free text available
- 2022-07-25
- 2022-07-26
- 2022-08-02
- 2022-08-09
- 2022-08-16
-
2022-08-23
Survey response — day 35, dose 3MedDRA: Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Related to cancer treatmentMedDRA releases: 2024-11 · check-in free text available
-
2022-08-30
Survey response — day 42, dose 3MedDRA: Unevaluable event — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Related to cancer treatmentMedDRA releases: 2024-11 · check-in free text available
- 2022-10-18
-
2023-01-19
Survey response — 6 months, dose 3MedDRA: Emergency care, Epistaxis, Platelet count decreased, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-01-19
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2023-01-20
-
2023-01-20
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Janssen/Johnson & Johnson | |
| 2 | 2021-12-24 | Moderna | No |
| 3 | 2022-07-19 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Difficulty sleeping
Systemic reaction (other): Night sweats 3 nights may be related to other conditions
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Slight itchy or prickly skin. May be due to cancer treatment
Systemic reaction (other): Cancer symptoms and cancer drugs overlap some of above none new
Systemic reaction (other): Night sweats most likely from cancer
Release 10 — day 14, dose 2
Symptoms: I had a rash on upper thigh. My oncologist said unlikely from my treatment. Treated with Allegra (2) until gone 3 days and still on 1 last day.
Release 12 — days 1–6 daily, dose 3
Systemic reaction (other): I am on chemo so only my sore arm at shot site is related. Possibly mild fatigue.
Systemic reaction (other): Probably chemo related
Systemic reaction (other): Cancer or chemo
Release 12 — day 35, dose 3
Symptoms: Related to cancer treatment
Release 12 — day 42, dose 3
Symptoms: Related to cancer treatment
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Emergency care | · | · | ✓ |
| SD | Epistaxis | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Platelet count decreased | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Chemotherapy | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | Insomnia | ✓ | ✓ | ✓ |
| SRO | Neoplasm malignant | · | · | ✓ |
| SRO | Night sweats | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Pruritus | · | · | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release